Literature DB >> 10615895

Parenteral ivermectin in Strongyloides hyperinfection.

P L Chiodini, A J Reid, M J Wiselka, R Firmin, J Foweraker.   

Abstract

Strongyloides hyperinfection, unresponsive to oral ivermectin and oral albendazole, was controlled by subcutaneous administration of a veterinary preparation of ivermectin.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10615895     DOI： 10.1016/s0140-6736(99)02744-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  18 in total

1.  Non-oral treatment with ivermectin for disseminated strongyloidiasis.

Authors:  Dahlene N Fusco; Jennifer A Downs; Michael J Satlin; Meera Pahuja; Liz Ramos; Philip S Barie; Lawrence Fleckenstein; Henry W Murray
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

2.  Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock.

Authors:  Jorge Ibrain Figueira Salluh; Guilherme Alvarenga Feres; Eduardo Velasco; Gustavo S Holanda; Luisa Toscano; Marcio Soares
Journal:  Intensive Care Med       Date:  2005-07-22       Impact factor: 17.440

3.  Evaluation of an indirect immunofluorescence assay for strongyloidiasis as a tool for diagnosis and follow-up.

Authors:  Marina Boscolo; Maria Gobbo; William Mantovani; Monica Degani; Mariella Anselmi; Geraldo Badona Monteiro; Stefania Marocco; Andrea Angheben; Manuela Mistretta; Maria Santacatterina; Stefano Tais; Zeno Bisoffi
Journal:  Clin Vaccine Immunol       Date:  2006-11-29

4.  Recurrent Streptococcus bovis meningitis in Strongyloides stercoralis hyperinfection after kidney transplantation: the dilemma in a non-endemic area.

Authors:  Taqi T Khan; Fatehi Elzein; Abdullah Fiaar; Faheem Akhtar
Journal:  Am J Trop Med Hyg       Date:  2014-01-06       Impact factor: 2.345

5.  Strongyloidiasis: a multifaceted disease.

Authors:  Swaytha Ganesh; Ruy J Cruz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-03

6.  Failure of ivermectin per rectum to achieve clinically meaningful serum levels in two cases of Strongyloides hyperinfection.

Authors:  Isaac I Bogoch; Kamran Khan; Howard Abrams; Caroline Nott; Elizabeth Leung; Lawrence Fleckenstein; Jay S Keystone
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

7.  Pulmonary Strongyloidiasis: The Varied Clinical Presentations.

Authors:  Babak Mokhlesi; Oksana Shulzhenko; Prasad S Garimella; Leslie Kuma; Catherine Monti
Journal:  Clin Pulm Med       Date:  2004-01

8.  Strongyloides hyperinfection syndrome following resection of meningioma.

Authors:  Clifford Leigh Shelton; Timothy Smith; Konstantina Karabatsou; Katherine Ajdukiewicz
Journal:  BMJ Case Rep       Date:  2012-06-15

9.  A sensitive and selective LC-MS/MS method for quantitation of ivermectin in human, mouse and monkey plasma: clinical validation.

Authors:  Yashpal S Chhonker; Liping Ma; Constant Edi; Daryl J Murry
Journal:  Bioanalysis       Date:  2018-10-16       Impact factor: 2.681

10.  Duodenal obstruction - an unusual presentation of Strongyloides stercoralis enteritis: a case report.

Authors:  Ruy J Cruz; Rodrigo Vincenzi; Bernardo M Ketzer
Journal:  World J Emerg Surg       Date:  2010-08-10       Impact factor: 5.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.